VAPA expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.78209999879675E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.07120000226413E-08 |
Normal-vs-Stage2 |
4.92750000025133E-07 |
Normal-vs-Stage3 |
2.390000E-04 |
Normal-vs-Stage4 |
8.383700E-02 |
Stage1-vs-Stage2 |
6.540600E-01 |
Stage1-vs-Stage3 |
8.340000E-01 |
Stage1-vs-Stage4 |
6.074400E-01 |
Stage2-vs-Stage3 |
6.439800E-01 |
Stage2-vs-Stage4 |
6.095800E-01 |
Stage3-vs-Stage4 |
7.780600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.84309994728005E-09 |
Normal-vs-AfricanAmerican |
2.74509999953487E-07 |
Normal-vs-Asian |
1.780780E-01 |
Caucasian-vs-AfricanAmerican |
9.272800E-01 |
Caucasian-vs-Asian |
8.985600E-01 |
AfricanAmerican-vs-Asian |
9.201800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.29589999842139E-08 |
Normal-vs-Female |
8.07270000000582E-05 |
Male-vs-Female |
5.403500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.54460999999273E-05 |
Normal-vs-Extreme_Weight |
3.72749999755229E-08 |
Normal-vs-Obese |
4.31340000051073E-07 |
Normal-vs-Extreme_Obese |
9.180100E-04 |
Normal_Weight-vs-Extreme_Weight |
3.933000E-01 |
Normal_Weight-vs-Obese |
8.171000E-01 |
Normal_Weight-vs-Extreme_Obese |
8.233200E-01 |
Extreme_Weight-vs-Obese |
4.725600E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.047800E-01 |
Obese-vs-Extreme_Obese |
9.097800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.037700E-03 |
Normal-vs-Age(41-60Yrs) |
4.96990000042885E-07 |
Normal-vs-Age(61-80Yrs) |
4.79630002381271E-09 |
Normal-vs-Age(81-100Yrs) |
2.19519999999918E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.501200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.289800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.333400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.881000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.366400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.776600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.19730000358587E-08 |
Normal-VS-Type2 PRCC |
1.30430000133686E-08 |
Normal-VS-KIRP CIMP |
7.646000E-01 |
Normal-VS-Unclassified PRCC |
8.27579999973516E-07 |
Type1 PRCC-VS-Type2 PRCC |
2.171800E-01 |
Type1 PRCC-VS-KIRP CIMP |
2.992700E-04 |
Type1 PRCC-VS-Unclassified PRCC |
7.669800E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.039500E-04 |
Type2 PRCC-VS-Unclassified PRCC |
5.606200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.817300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.30930044583977E-10 |
Normal-vs-N1 |
2.932400E-02 |
Normal-vs-N2 |
1.804350E-03 |
N0-vs-N1 |
2.755500E-03 |
N0-vs-N2 |
8.630800E-01 |
N1-vs-N2 |
1.909630E-01 |
|
|